Related references
Note: Only part of the references are listed.Current concepts and progress in RSV vaccine development
Aleks K. Guvenel et al.
EXPERT REVIEW OF VACCINES (2014)
Respiratory Syncytial Virus Can Infect Basal Cells and Alter Human Airway Epithelial Differentiation
B. David Persson et al.
PLOS ONE (2014)
Nanoparticle Vaccines Encompassing the Respiratory Syncytial Virus (RSV) G Protein CX3C Chemokine Motif Induce Robust Immunity Protecting from Challenge and Disease
Patricia A. Jorquera et al.
PLOS ONE (2013)
Structure-Based Design of a Fusion Glycoprotein Vaccine for Respiratory Syncytial Virus
Jason S. McLellan et al.
SCIENCE (2013)
Respiratory syncytial virus interaction with human airway epithelium
Remi Villenave et al.
TRENDS IN MICROBIOLOGY (2013)
Respiratory syncytial virus immunization program for the United States: Impact of performance determinants of a theoretical vaccine
Stephane A. Regnier
VACCINE (2013)
In vitro modeling of respiratory syncytial virus infection of pediatric bronchial epithelium, the primary target of infection in vivo
Remi Villenave et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2012)
Viruslike Particle Vaccine Induces Protection Against Respiratory Syncytial Virus Infection in Mice
Fu-Shi Quan et al.
JOURNAL OF INFECTIOUS DISEASES (2011)
Identification of nucleolin as a cellular receptor for human respiratory syncytial virus
Farnoosh Tayyari et al.
NATURE MEDICINE (2011)
Differential cytopathogenesis of respiratory syncytial virus prototypic and clinical isolates in primary pediatric bronchial epithelial cells
Remi Villenave et al.
VIROLOGY JOURNAL (2011)
Respiratory Syncytial Virus F and G Proteins Induce Interleukin 1α, CC, and CXC Chemokine Responses by Normal Human Bronchoepithelial Cells
Christine M. Oshansky et al.
JOURNAL OF INFECTIOUS DISEASES (2010)
Newcastle Disease Virus-Like Particles Containing Respiratory Syncytial Virus G Protein Induced Protection in BALB/c Mice, with No Evidence of Immunopathology
Matthew R. Murawski et al.
JOURNAL OF VIROLOGY (2010)
Vaccination To Induce Antibodies Blocking the CX3C-CX3CR1 Interaction of Respiratory Syncytial Virus G Protein Reduces Pulmonary Inflammation and Virus Replication in Mice
Wenliang Zhang et al.
JOURNAL OF VIROLOGY (2010)
Global burden of acute lower respiratory infections due to respiratory syncytial virus in young children: a systematic review and meta-analysis
Harish Nair et al.
LANCET (2010)
CX3CR1 is required for airway inflammation by promoting T helper cell survival and maintenance in inflamed lung
Cyrille Mionnet et al.
NATURE MEDICINE (2010)
In vitro susceptibility to rhinovirus infection is greater for bronchial than for nasal airway epithelial cells in human subjects
Nilceia Lopez-Souza et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2009)
Therapeutic Monoclonal Antibody Treatment Targeting Respiratory Syncytial Virus (RSV) G Protein Mediates Viral Clearance and Reduces the Pathogenesis of RSV Infection in BALB/c Mice
Lia M. Haynes et al.
JOURNAL OF INFECTIOUS DISEASES (2009)
The Burden of Respiratory Syncytial Virus Infection in Young Children
Caroline Breese Hall et al.
NEW ENGLAND JOURNAL OF MEDICINE (2009)
Motile Cilia of Human Airway Epithelia Are Chemosensory
Alok S. Shah et al.
SCIENCE (2009)
Respiratory Syncytial Virus Proteins Modulate Suppressors of Cytokine Signaling 1 and 3 and the Type I Interferon Response to Infection by a Toll-Like Receptor Pathway
Christine M. Oshansky et al.
VIRAL IMMUNOLOGY (2009)
Expression of chemokine receptor CX3CR1 in infants with respiratory syncytial virus bronchiolitis
Alma-Martina Cepika et al.
PEDIATRIC ALLERGY AND IMMUNOLOGY (2008)
Infection of ciliated cells by human parainfluenza virus type 3 in an in vitro model of human airway epithelium
LQ Zhang et al.
JOURNAL OF VIROLOGY (2005)
Human and avian influenza viruses target different cell types in cultures of human airway epithelium
MN Matrosovich et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2004)
Anti-G protein antibody responses to respiratory syncytial virus infection or vaccination are associated with inhibition of G protein CX3C-CX3CR1 binding and leukocyte chemotaxis
JL Harcourt et al.
JOURNAL OF INFECTIOUS DISEASES (2004)
Respiratory syncytial virus infection of human airway epithelial cells is polarized, specific to ciliated cells, and without obvious cytopathology
LQ Zhang et al.
JOURNAL OF VIROLOGY (2002)
Contribution of the respiratory syncytial virus G glycoprotein and its secreted and membrane-bound forms to virus replication in vitro and in vivo
MN Teng et al.
VIROLOGY (2001)
CX3C chemokine mimicry by respiratory syncytial virus G glycoprotein
RA Tripp et al.
NATURE IMMUNOLOGY (2001)
Functional analysis of recombinant respiratory syncytial virus deletion mutants lacking the small hydrophobic and/or attachment glycoprotein gene
S Techaarpornkul et al.
JOURNAL OF VIROLOGY (2001)
Interferon-γ stimulates fractalkine expression in human bronchial epithelial cells and regulates mononuclear cell adherence
K Fujimoto et al.
AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY (2001)
Expression of CX3CR1 chemokine receptors on neurons and their role in neuronal survival
O Meucci et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2000)
The fusion glycoprotein of human respiratory syncytial virus facilitates virus attachment and infectivity via an interaction with cellular heparan sulfate
SA Feldman et al.
JOURNAL OF VIROLOGY (2000)
Serum neutralizing antibody titers of seropositive chimpanzees immunized with vaccines coformulated with natural fusion and attachment proteins of respiratory syncytial virus
GE Hancock et al.
JOURNAL OF INFECTIOUS DISEASES (2000)
Share Paper
